BRC Immunology Platform provides comprehensive and precise potency testing services for antibody and protein products, deeply evaluating the biological activity, binding ability, and structural integrity of antibody and protein products, providing strong support for product quality control, R&D optimization, and clinical applications. BRC Biotechnology employs a variety of cutting-edge testing methods, including enzyme-linked immunosorbent assay (ELISA), affinity determination, and Western Blot, to ensure the reliability and accuracy of test results.